Global Transmucosal Drug Delivery Market Research Report 2019

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Transmucosal Drug Delivery Revenue
• 1.4 Market by Type
  • 1.4.1 Global Transmucosal Drug Delivery Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Passive Transdermal Drug Delivery
  • 1.4.3 Active Transdermal Drug Delivery
• 1.5 Market by Application
  • 1.5.1 Global Transmucosal Drug Delivery Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital
  • 1.5.3 Clinic
  • 1.5.4 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Transmucosal Drug Delivery Market Perspective (2015-2026)
• 2.2 Global Transmucosal Drug Delivery Growth Trends by Regions
  • 2.2.1 Transmucosal Drug Delivery Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Transmucosal Drug Delivery Historic Market Share by Regions (2015-2020)
  • 2.2.3 Transmucosal Drug Delivery Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Transmucosal Drug Delivery Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Transmucosal Drug Delivery Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Transmucosal Drug Delivery Players by Market Size
  • 3.1.1 Global Top Transmucosal Drug Delivery Players by Revenue (2015-2020)
  • 3.1.2 Global Transmucosal Drug Delivery Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Transmucosal Drug Delivery Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Transmucosal Drug Delivery Market Concentration Ratio
  • 3.2.1 Global Transmucosal Drug Delivery Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Transmucosal Drug Delivery Revenue in 2019
• 3.3 Transmucosal Drug Delivery Key Players Head office and Area Served
• 3.4 Key Players Transmucosal Drug Delivery Product Solution and Service
• 3.5 Date of Enter into Transmucosal Drug Delivery Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Transmucosal Drug Delivery Historic Market Size by Type (2015-2020)
• 4.2 Global Transmucosal Drug Delivery Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Transmucosal Drug Delivery Market Size by Application (2015-2020)
• 5.2 Global Transmucosal Drug Delivery Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Transmucosal Drug Delivery Market Size (2015-2020)
• 6.2 Transmucosal Drug Delivery Key Players in North America (2019-2020)
• 6.3 North America Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 6.4 North America Transmucosal Drug Delivery Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Transmucosal Drug Delivery Market Size (2015-2020)
• 7.2 Transmucosal Drug Delivery Key Players in Europe (2019-2020)
• 7.3 Europe Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 7.4 Europe Transmucosal Drug Delivery Market Size by Application (2015-2020)

8 China

• 8.1 China Transmucosal Drug Delivery Market Size (2015-2020)
• 8.2 Transmucosal Drug Delivery Key Players in China (2019-2020)
• 8.3 China Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 8.4 China Transmucosal Drug Delivery Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Transmucosal Drug Delivery Market Size (2015-2020)
• 9.2 Transmucosal Drug Delivery Key Players in Japan (2019-2020)
• 9.3 Japan Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 9.4 Japan Transmucosal Drug Delivery Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Transmucosal Drug Delivery Market Size (2015-2020)
• 10.2 Transmucosal Drug Delivery Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 10.4 Southeast Asia Transmucosal Drug Delivery Market Size by Application (2015-2020)

11 India

• 11.1 India Transmucosal Drug Delivery Market Size (2015-2020)
• 11.2 Transmucosal Drug Delivery Key Players in India (2019-2020)
• 11.3 India Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 11.4 India Transmucosal Drug Delivery Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Transmucosal Drug Delivery Market Size (2015-2020)
• 12.2 Transmucosal Drug Delivery Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Transmucosal Drug Delivery Market Size by Type (2015-2020)
• 12.4 Central & South America Transmucosal Drug Delivery Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 3M Pharmaceuticals
  • 13.1.1 3M Pharmaceuticals Company Details
  • 13.1.2 3M Pharmaceuticals Business Overview
  • 13.1.3 3M Pharmaceuticals Transmucosal Drug Delivery Introduction
  • 13.1.4 3M Pharmaceuticals Revenue in Transmucosal Drug Delivery Business (2015-2020))
  • 13.1.5 3M Pharmaceuticals Recent Development
• 13.2 Acrux Limited
  • 13.2.1 Acrux Limited Company Details
  • 13.2.2 Acrux Limited Business Overview
  • 13.2.3 Acrux Limited Transmucosal Drug Delivery Introduction
  • 13.2.4 Acrux Limited Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.2.5 Acrux Limited Recent Development
• 13.3 ALZA Corporation
  • 13.3.1 ALZA Corporation Company Details
  • 13.3.2 ALZA Corporation Business Overview
  • 13.3.3 ALZA Corporation Transmucosal Drug Delivery Introduction
  • 13.3.4 ALZA Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.3.5 ALZA Corporation Recent Development
• 13.4 Antares Pharma, Inc.
  • 13.4.1 Antares Pharma, Inc. Company Details
  • 13.4.2 Antares Pharma, Inc. Business Overview
  • 13.4.3 Antares Pharma, Inc. Transmucosal Drug Delivery Introduction
  • 13.4.4 Antares Pharma, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.4.5 Antares Pharma, Inc. Recent Development
• 13.5 Apricus BioSciences, Inc
  • 13.5.1 Apricus BioSciences, Inc Company Details
  • 13.5.2 Apricus BioSciences, Inc Business Overview
  • 13.5.3 Apricus BioSciences, Inc Transmucosal Drug Delivery Introduction
  • 13.5.4 Apricus BioSciences, Inc Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.5.5 Apricus BioSciences, Inc Recent Development
• 13.6 Aveva Drug Delivery Systems
  • 13.6.1 Aveva Drug Delivery Systems Company Details
  • 13.6.2 Aveva Drug Delivery Systems Business Overview
  • 13.6.3 Aveva Drug Delivery Systems Transmucosal Drug Delivery Introduction
  • 13.6.4 Aveva Drug Delivery Systems Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.6.5 Aveva Drug Delivery Systems Recent Development
• 13.7 Corium International, Inc
  • 13.7.1 Corium International, Inc Company Details
  • 13.7.2 Corium International, Inc Business Overview
  • 13.7.3 Corium International, Inc Transmucosal Drug Delivery Introduction
  • 13.7.4 Corium International, Inc Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.7.5 Corium International, Inc Recent Development
• 13.8 DURECT Corporation
  • 13.8.1 DURECT Corporation Company Details
  • 13.8.2 DURECT Corporation Business Overview
  • 13.8.3 DURECT Corporation Transmucosal Drug Delivery Introduction
  • 13.8.4 DURECT Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.8.5 DURECT Corporation Recent Development
• 13.9 Generex Biotechnology Corporation
  • 13.9.1 Generex Biotechnology Corporation Company Details
  • 13.9.2 Generex Biotechnology Corporation Business Overview
  • 13.9.3 Generex Biotechnology Corporation Transmucosal Drug Delivery Introduction
  • 13.9.4 Generex Biotechnology Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.9.5 Generex Biotechnology Corporation Recent Development
• 13.10 Inovio Pharmaceuticals, Inc.
  • 13.10.1 Inovio Pharmaceuticals, Inc. Company Details
  • 13.10.2 Inovio Pharmaceuticals, Inc. Business Overview
  • 13.10.3 Inovio Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
  • 13.10.4 Inovio Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 13.10.5 Inovio Pharmaceuticals, Inc. Recent Development
• 13.11 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)
  • 10.11.1 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Company Details
  • 10.11.2 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Business Overview
  • 10.11.3 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Transmucosal Drug Delivery Introduction
  • 10.11.4 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.11.5 Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) Recent Development
• 13.12 MedPharm LTD
  • 10.12.1 MedPharm LTD Company Details
  • 10.12.2 MedPharm LTD Business Overview
  • 10.12.3 MedPharm LTD Transmucosal Drug Delivery Introduction
  • 10.12.4 MedPharm LTD Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.12.5 MedPharm LTD Recent Development
• 13.13 Mylan, Inc.
  • 10.13.1 Mylan, Inc. Company Details
  • 10.13.2 Mylan, Inc. Business Overview
  • 10.13.3 Mylan, Inc. Transmucosal Drug Delivery Introduction
  • 10.13.4 Mylan, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.13.5 Mylan, Inc. Recent Development
• 13.14 Nemaura Pharma Ltd
  • 10.14.1 Nemaura Pharma Ltd Company Details
  • 10.14.2 Nemaura Pharma Ltd Business Overview
  • 10.14.3 Nemaura Pharma Ltd Transmucosal Drug Delivery Introduction
  • 10.14.4 Nemaura Pharma Ltd Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.14.5 Nemaura Pharma Ltd Recent Development
• 13.15 Nitto Denko Corporation
  • 10.15.1 Nitto Denko Corporation Company Details
  • 10.15.2 Nitto Denko Corporation Business Overview
  • 10.15.3 Nitto Denko Corporation Transmucosal Drug Delivery Introduction
  • 10.15.4 Nitto Denko Corporation Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.15.5 Nitto Denko Corporation Recent Development
• 13.16 Noven Pharmaceuticals, Inc.
  • 10.16.1 Noven Pharmaceuticals, Inc. Company Details
  • 10.16.2 Noven Pharmaceuticals, Inc. Business Overview
  • 10.16.3 Noven Pharmaceuticals, Inc. Transmucosal Drug Delivery Introduction
  • 10.16.4 Noven Pharmaceuticals, Inc. Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.16.5 Noven Pharmaceuticals, Inc. Recent Development
• 13.17 Pantec Biosolutions AG
  • 10.17.1 Pantec Biosolutions AG Company Details
  • 10.17.2 Pantec Biosolutions AG Business Overview
  • 10.17.3 Pantec Biosolutions AG Transmucosal Drug Delivery Introduction
  • 10.17.4 Pantec Biosolutions AG Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.17.5 Pantec Biosolutions AG Recent Development
• 13.18 Tapemark
  • 10.18.1 Tapemark Company Details
  • 10.18.2 Tapemark Business Overview
  • 10.18.3 Tapemark Transmucosal Drug Delivery Introduction
  • 10.18.4 Tapemark Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.18.5 Tapemark Recent Development
• 13.19 tesa Labtec GmbH
  • 10.19.1 tesa Labtec GmbH Company Details
  • 10.19.2 tesa Labtec GmbH Business Overview
  • 10.19.3 tesa Labtec GmbH Transmucosal Drug Delivery Introduction
  • 10.19.4 tesa Labtec GmbH Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.19.5 tesa Labtec GmbH Recent Development
• 13.20 TEVA Pharmaceutical Industries Ltd.
  • 10.20.1 TEVA Pharmaceutical Industries Ltd. Company Details
  • 10.20.2 TEVA Pharmaceutical Industries Ltd. Business Overview
  • 10.20.3 TEVA Pharmaceutical Industries Ltd. Transmucosal Drug Delivery Introduction
  • 10.20.4 TEVA Pharmaceutical Industries Ltd. Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.20.5 TEVA Pharmaceutical Industries Ltd. Recent Development
• 13.21 Zosano Pharma
  • 10.21.1 Zosano Pharma Company Details
  • 10.21.2 Zosano Pharma Business Overview
  • 10.21.3 Zosano Pharma Transmucosal Drug Delivery Introduction
  • 10.21.4 Zosano Pharma Revenue in Transmucosal Drug Delivery Business (2015-2020)
  • 10.21.5 Zosano Pharma Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer